Net profit of Alembic Pharmaceuticals rose 98.74% to Rs 18.90 crore in the quarter ended March 2012 as against Rs 9.51 crore during the previous quarter ended March 2011. Sales rose 6.84% to Rs 316.76 crore in the quarter ended March 2012 as against Rs 296.47 crore during the previous quarter ended March 2011.
For the audited full year, net profit rose 47.90% to Rs 120.54 crore in the year ended March 2012 as against Rs 81.50 crore during the previous year ended March 2011. Sales rose 18.02% to Rs 1371.25 crore in the year ended March 2012 as against Rs 1161.86 crore during the previous year ended March 2011.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2012 | Mar. 2011 | % Var. | Mar. 2012 | Mar. 2011 | % Var. |
| Sales | 316.76 | 296.47 | 7 | 1371.25 | 1161.86 | 18 |
| OPM % | 12.48 | 8.82 | 41 | 15.28 | 13.40 | 14 |
| PBDT | 34.27 | 19.82 | 73 | 183.81 | 131.92 | 39 |
| PBT | 25.35 | 11.98 | 112 | 150.16 | 102.33 | 47 |
| NP | 18.90 | 9.51 | 99 | 120.54 | 81.50 | 48 |